The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca has ...
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...
“Since I’ve been vice president, we have capped the cost of prescription medication for seniors at $2,000 a year.” The development of green inhalers jeopardizes those gains. Drug companies will be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback